A Study of ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry Study

TerminatedOBSERVATIONAL
Enrollment

167

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Solid Organ Tumors
Trial Locations (25)

11355

The New York Hospital Medical Center of Queens, Flushing

11501

Winthrop University Hospital, Mineola

11733

North Shore Hematology Oncology, East Setauket

12208

Albany Thoracic & Esophageal Surgery, Albany

16505

The Regional Cancer Center, Erie

26508

Heiskell, King, Burns & Tallman Surgical Associates, Inc., Morgantown

32804

Orlando Cardiovascular Institute PA, Orlando

33021

The Center For Gynecologic Oncology, Hollywood

33143

GYN Oncology of Miami, Miami

33173

Miami International Surgical Services, Miami

33308

Broward Oncology Associates, P.A., Fort Lauderdale

33435

Collaborative Research Group, Boynton Beach

35213

Cardio-Thoracic Surgeons, P.C., Birmingham

40503

Central Baptist Hospital Clinical Research Center, Lexington

42003

Oncology Associates of West Kentucky, Paducah

44106

Center for Clinical Research and Technology University Hospitals of Cleveland, Cleveland

48439

Grand Blanc Surgical Specialist, Grand Blanc

50309

Iowa Clinic, Des Moines

60076

Edward H. Kaplan, M.D. & Associates, Skokie

77024

Barry S Siller MD, Houston

77054

Colorectal Surgical Associates, Houston

77090

Northwest Cancer Center, Houston

78229

Cancer Care Centers of South Texas, San Antonio

94609

Hematology Oncology Associates, Oakland

99202

Cancer Care Northwest, Spokane

Sponsors
All Listed Sponsors
lead

Precision Therapeutics

INDUSTRY